Timed-release glaucoma drug insert shows promise as alternative to daily drops

A medicated silicone ring that rests on the surface of the eye and slowly releases medication reduced eye pressure in glaucoma patients by about 20 percent over six months. These clinical trial results are the first published research on this type of continuous glaucoma drug delivery technology, which could benefit nearly 3 million people with glaucoma in the United States.